H Clinical Executes Latin America’s Most Significant Home Trial Operation in History
H Clinical provided the logistics and home visit support for Janssen’s NCT04505722 Ensemble clinical trial in Argentina, Brazil, Colombia, Mexico, and Peru. This trial resulted in a single-dose COVID-19 vaccine that received FDA’s emergency use authorization on February 27, 2021, for use in individuals 18 years of age and older. For more information see: FDA Issues Emergency Use Authorization for Third COVID-19 Vaccine | FDA
We provide in-home health services for clinical trials across Latin America.
H Clinical is the leader in decentralized trial support in Latin America. H Clinical empowers sponsors to reach more patients and patients to participate from the comfort of home. Through an extensive network of GCP trained home health providers, logistics infrastructure, and clinical trial coverage from the Rio Grande to Patagonia, H Clinical is bringing clinical research home.
TAMPA - U.S./CORPORATE HEADQUATERS7901 4th St N, Suite 5706, St. Petersburg, FL 33702
MEXICO CITY – CENTRAL AMERICAN HEADQUARTERSAv. Insurgentes Sur No1605, Piso 15 Mod IV, Col. San Jose Insurgentes, Del. Benito Juarez, CP 03900, CDMX, Mexico
SAO PAULO – SOUTH AMERICAN HEADQUARTERSRua Salviano Jose Da Silva, No 225, Bairro El Dorado, Sao Jose Dos Campos, SP, Brazil